Bvf Inc Merus N.V. Transaction History

Bvf Inc

  • $3.15 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$39.81 - $60.2 $4.25 Million - $6.43 Million
106,800 Added 9.11%
1,279,049 $75.7 Million
Q1 2024

May 15, 2024
SELL
$28.03 - $51.82 $44.3 Million - $81.9 Million
-1,580,171 Reduced 57.41%
1,172,249 $52.8 Million
Q3 2023

Nov 14, 2023
BUY
$20.13 - $27.29 $23.1 Million - $31.4 Million
1,150,000 Added 71.77%
2,752,420 $64.9 Million
Q2 2023

Aug 14, 2023
SELL
$18.33 - $27.18 $25.2 Million - $37.4 Million
-1,376,000 Reduced 46.2%
1,602,420 $42.2 Million
Q4 2022

Feb 14, 2023
SELL
$12.8 - $23.66 $5.96 Million - $11 Million
-466,000 Reduced 13.53%
2,978,420 $46.1 Million
Q3 2022

Nov 14, 2022
SELL
$18.64 - $28.93 $11.9 Million - $18.4 Million
-637,011 Reduced 15.61%
3,444,420 $69 Million
Q2 2022

Aug 15, 2022
SELL
$13.98 - $29.25 $749,887 - $1.57 Million
-53,640 Reduced 1.3%
4,081,431 $92.4 Million
Q4 2021

Feb 14, 2022
BUY
$20.0 - $32.29 $82.7 Million - $134 Million
4,135,071 New
4,135,071 $131 Million
Q3 2021

Nov 15, 2021
SELL
$16.48 - $27.23 $120 Million - $198 Million
-7,285,071 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$16.14 - $29.11 $23.9 Million - $43.1 Million
1,479,500 Added 25.48%
7,285,071 $152 Million
Q4 2020

Feb 12, 2021
BUY
$11.4 - $18.36 $1.82 Million - $2.94 Million
160,000 Added 2.83%
5,805,571 $102 Million
Q3 2020

Nov 13, 2020
BUY
$10.57 - $16.0 $5.87 Million - $8.88 Million
555,000 Added 10.9%
5,645,571 $67.7 Million
Q2 2020

Aug 14, 2020
BUY
$10.5 - $17.36 $16.2 Million - $26.8 Million
1,545,917 Added 43.61%
5,090,571 $81.9 Million
Q1 2020

May 15, 2020
BUY
$11.34 - $19.44 $4.25 Million - $7.29 Million
375,000 Added 11.83%
3,544,654 $42.9 Million
Q4 2019

Feb 14, 2020
SELL
$14.08 - $18.5 $20.7 Million - $27.2 Million
-1,469,759 Reduced 31.68%
3,169,654 $44.6 Million
Q2 2019

Aug 14, 2019
BUY
$12.93 - $16.83 $1.29 Million - $1.67 Million
99,500 Added 2.19%
4,639,413 $68 Million
Q1 2019

May 15, 2019
BUY
$11.09 - $15.83 $277,250 - $395,750
25,000 Added 0.55%
4,539,913 $67.1 Million
Q4 2018

Feb 14, 2019
BUY
$11.46 - $20.81 $6.88 Million - $12.5 Million
600,000 Added 15.33%
4,514,913 $63.2 Million
Q2 2018

Aug 14, 2018
BUY
$16.77 - $22.76 $25.1 Million - $34 Million
1,495,470 Added 61.81%
3,914,913 $89.1 Million
Q1 2018

May 07, 2018
BUY
$16.07 - $19.87 $38.9 Million - $48.1 Million
2,419,443 New
2,419,443 $44.8 Million

Others Institutions Holding MRUS

# of Institutions
200
Shares Held
61.9M
Call Options Held
243K
Put Options Held
300K
View Full List

About Merus N.V.

MRUS Quotes by TradingView
  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email